
Cefta-One-S Injection
Marketer
Avita Laboratories Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Cefta-One-S Injection
Cefta-One-S Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism prevents microbial proliferation and infection spread. Administration must be overseen by a medical professional; adherence to the prescribed schedule is crucial. Complete the full treatment course, even with symptom improvement; premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and indigestion are potential side effects; worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (including rashes, itching, swelling, or breathing difficulties). Inform your physician of all current medications before starting Cefta-One-S Injection. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration support recovery. Monitoring through lab tests may be employed to assess the medicine's impact.
Primary Ingredients of Cefta-One-S Injection
No text provided to rephrase.
Uses of Cefta-One-S Injection
Infections caused by bacteria
Major Benefits of Cefta-One-S Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cefta-One-S Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefta-One-S Injection:
Administering this medication will be handled by your physician or their qualified staff; self-medication is strictly prohibited.
How Cefta-One-S Injection works:
Ceftriaxone and sulbactam, the components of Cefta-One-S Injection, act synergistically to combat bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial enzymes that would otherwise degrade ceftriaxone, thus improving its efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from co-administering Cefta-One-S Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The administration of Cefta-One-S Injection during gestation is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, clinical data in humans are scarce.
Breast feedingCAUTION
Administering Cefta-One-S Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Cefta-One-S Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data on Cefta-One-S Injection use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should receive Cefta-One-S Injection cautiously, potentially requiring dosage modification. Mild to moderate hepatic dysfunction does not necessitate Cefta-One-S Injection dose alteration; however, physician consultation is advised for all cases.
What if you forget to take Cefta-One-S Injection :
Omit a Cefta-One-S Injection dose? Seek your physician's guidance.
Facts to Know About Cefta-One-S Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
